09.09.2026, 17:46

Promomed launches flagship drug in Kazakhstan

MOSCOW. Sept 9 (Interfax) – Kazakhstan's Health Ministry has granted Promomed a registration certificate for its tirzepatide-based drug, used to treat type 2 diabetes and obesity, the Russian pharmaceutical company said.

To read the full news articles, Subscribe.

08:21PM
Oil transportation via Caspian Pipeline Consortium disrupted by drone attacks on Tuesday, later resumed - Kazakh energy ministry

05:40PM
National Bank chief sees no significant exchange rate shifts if external conditions hold

05:29PM
Samruk-Kazyna CEO briefs Tokayev on major infrastructure projects

04:29PM
Uzbekistan Airports, My Freighter launch e-commerce goods delivery from China to Europe via Tashkent

04:25PM
Trump notes enhanced bilateral strategic, economic cooperation in Tajikistan Independence Day greetings

04:24PM
Fish processing plant under construction in East Kazakhstan

04:06PM
Uzbekneftegaz drills five wells in Ustyurt in search of new hydrocarbon reserves

04:02PM
AVERAGE WEIGHTED RATE ON SEPTEMBER 9, 2026 IS 456.89 TENGE FOR $1

03:27PM
Eurasian Economic Union and India prepared to agree on preferential tariffs within trade agreement, hope it will be wide-reaching - Russian first deputy PM

03:21PM
Foreign leaders congratulate Tajik president on 35th anniversary of Tajikistan's independence

03:09PM
Kazakhstan, India agree on projects worth $122 mln

01:17PM
ADCB Kazakhstan plans to triple project financing to 7.5 trillion tenge

12:47PM
Belarusian, Kazakh reconnaissance units train together in joint exercise

12:36PM
Solidcore to pause shareholder payouts after buyback to focus on growth

Press center

https://press.interfax.kz

WE EXPECT A SURGE IN INFLATION IN EARLY 2026 DUE TO TAX REFORM, BUT IT WILL BE ABSORBED BY YEAR-END

KAZAKHSTAN TO ACHIEVE FULL DAIRY SELF-SUFFICIENCY BY 2027, BUT IMPORTS STILL NEEDED

KAZAKHSTAN CAN BECOME A REGIONAL LEADER IN MINERAL EXPLORATION

COUNTRIES TRYING TO BE FRIENDLY WITH EVERYONE CAN BENEFIT AND BECOME MORE ATTRACTIVE FOR INVESTMENT

Promomed launches flagship drug in Kazakhstan

Press center